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Abstract
The capacity of the remodelling immune responses during stress (named immune plasticity) is
fundamental to reach successful ageing. We herein report two pivotal experimental models in
order to demonstrate the relevance of the immune plasticity in ageing and successful ageing. These
two experimental models will be compared with the capacity in remodelling the immune response
in human centenarians. With regard to experimental models, one model is represented by the
circadian rhythms of immune responses, the other one is the immune responses during partial
hepatectomy/liver regeneration (pHx). The latter is suggestive because it mimics the
immunosenescence and chronic inflammation 48 h after partial hepatectomy in the young through
the continuous production of IL-6, which is the main cause of immune plasticity lack in ageing. The
constant production of IL-6 leads to abnormal increments of zinc-bound Metallothionein (MT),
which is in turn unable in zinc release in ageing. As a consequence, low zinc ion bioavailability
appears for thymic and extrathymic immune efficiency, in particular of liver NKT cells bearing TCR
γδ. The remodelling during the circadian cycle and during pHx of zinc-bound MT confers the
immune plasticity of liver NKT γδ cells and NK cells in young and very old mice, not in old mice.
With regard to human centenarians and their capacity in remodelling the immune response with
respect to elderly, these exceptional individuals display low zinc-bound MT associated with: a)
satisfactory intracellular zinc ion availability, b)  more capacity in zinc release by MT, c)  less
inflammation due to low gene expression of IL-6 receptor (gp130), d) increased levels of IFN-
gamma and number of NKT cell bearing TCR γδ. Moreover, some polymorphisms for MT tested
in PBMCs from human donors are related to successful ageing. In conclusion, zinc-bound MT
homeostasis is fundamental to confer the immune plasticity that is a condition "sine qua non" to
achieve healthy ageing and longevity.
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Background
Immune plasticity is a condition "sine qua non" for
health ageing. The absence of the plasticity leads the
organism to be a "low responder" to oxidative stress with
subsequent appearance of age-related diseases. The
remodelling of the immune system to various harmful
stimuli allows a prompt immune response and the organ-
ism becomes a "high responder". Therefore, the capacity
in the remodelling can be considered the plasticity of the
immune system against the oxidative stress. The lack of
this capacity leads the cells of the immune system to
undergo to cell-death or necrosis triggered by oxidative
stress [1,2]. Such a plasticity is a common event in young-
adult age during transient stress-like conditions. During
ageing, the capacity of the remodelling of the immune sys-
tem is very limited because the stress-like condition is
chronic [2]. This phenomenon allows reduced immune
responses to oxidative stress and a low cellular capacity in
DNA-repair [3]. As a consequence, the risk of the appear-
ance of age-related diseases, i.e. cancer and infections, is
high [3]. On the other hand, the "free radical theory",
which takes into account the production of free radicals
by oxidative stress, is the more common theory of the age-
ing process [4]. The molecular basis of the absence of the
immune plasticity in ageing is poor understood and, at
the same time, poor also studied up to ten years ago when
the scientific community has seen an high increment of
exceptional individuals, like centenarians, among elderly
people. Indeed, healthy centenarians differ from "nor-
mal" aged individuals for their optimal metabolic com-
pensation and immune response and for the ability to
efficiently counter the alteration of the oxidative status
typical of ageing. In this context, various hypotheses have
been proposed in order to reach successful ageing. Lim-
ited inflammation, higher homing of stem cells to substi-
tute the damaged cells, an increased capacity in DNA-
repair and, finally, a major genomic integrity are charac-
teristics of oldest individuals [5]. However, the capacity of
the remodelling of the immune system can be also pivotal
in these exceptional individuals and, as such, an
improved immune plasticity. In this context, the role
played by zinc and Metallothioneins (MT) may be crucial
for the following reasons. First, zinc is a trace element
indispensable for the efficiency of the immune system
both in thymic and extrathymic T-cell pathways [6,7], and
this latter is fundamental in order to compensate thymic
failure in ageing [8]. Second, MT is relevant in zinc seques-
tering and in zinc release for the immune efficiency and
antioxidant response during transient stress [9]. The zinc
release by MT does not occur in ageing because stress-like
condition is chronic leading to low zinc ion bioavailabil-
ity for immune efficiency and for zinc-dependent biolog-
ical functions, such as enzyme antioxidant activity and
DNA-repair [10]. Third, the gene expression of MT is
induced by pro-inflammatory cytokines (IL-1, IL-6 and
TNF-α) during stress and inflammation [11]. In addition,
it has been recently shown that IL-6 regulates the zinc
transporter Zip14 in liver and contributes to the hypozin-
cemia of the acute-phase response coupled with enhanced
MTmRNA induction [12]. Therefore, the increment of
these cytokines, especially of IL-6, in ageing leads to
abnormal increase of MT associated with low intracellular
zinc ion bioavailability and impaired immune response
[10]. Consistent with these findings, zinc and MT home-
ostasis is crucial in conferring immune plasticity during
ageing taking also into account that satisfactory zinc ion
bioavailability is observed in human centenarians [1]. In
the present paper, two relevant experimental models are
reported in order to demonstrate the relevance of the
immune plasticity in ageing: the variations of the immune
functions a) during the circadian cycle and b) during the
compensatory liver growth after partial hepatectomy. The
choice of these two experimental models is based by pre-
vious findings showing the impact that the thymic circa-
dian variations [13] and the liver extrathymic T-cell
pathway [1] have in the economy of the immune response
in ageing and successful ageing. In addition, the model of
young partial hepatectomy/liver regeneration is very inter-
esting because, other than a good model for the study of
acute and chronic inflammation, it mimics the ageing
process in thymic failure and in impaired peripheral
immune efficiency at 48 hr after partial hepatectomy in
young pHx mice [14]. Young, old and very old mice were
used in both experimental models. A parallelism with eld-
erly and nonagenarian/centenarians is reported with a
special focus on some MT, IL-6 and TNF-alpha polymor-
phisms because related to successful ageing or to the
appearance of age-related diseases in dependence of the
genotype considered.
Immune plasticity: model of the circadian cycle 
in mice
Young mice display fluctuating variations in plasma zinc
and in thymic endocrine activity during the circadian
cycle with nocturnal peaks. By contrast, no significant var-
iations occur in old mice during the circadian cycle with
an absence of nocturnal peaks [13]. This absence is also
observed in peripheral immune efficiency. In particular,
the low Natural Killer (NK) cell activity observed in old
mice during the light period is also maintained during the
dark with no significant variations during the whole circa-
dian cycle [1,13,15]. Such a defect in old mice is closely
related to the appearance of age-related diseases (cancer
and infection) and subsequent death [13] (see Table 1).
Conversely, immune peripheral variations occur in
young-adult mice (Table 1) coupled with the capacity of
young mice to respond to external antigenic stimuli and,
subsequently in avoiding diseases triggered by the oxida-
tive stress, via circadian variations of neuroendocrine
mediators (cortisol, melatonin, insulin like growth factor)Immunity & Ageing 2007, 4:7 http://www.immunityageing.com/content/4/1/7
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[16]. It has been shown that both IL-2 and IFN-γ, that are
relevant for NK cell activity, display nocturnal peaks in
young mice [1,17]. Nocturnal peaks of thymic and periph-
eral immune functions also occur in very old mice [1]. It
has been also shown that the circadian variations of NK
cells are under the control of a specific gene (Period 2) [17]
located in the suprachiasmatic nuclues and belonging to
Period family genes [18]. In absence of these "clock genes",
the innate immune variations are lost with the appearance
of tumours [19]. Therefore, independently by the mecha-
nism/s or genes involved, all these findings are clear evi-
dences that the immune variations during the circadian
cycle are fundamental in maintaining the immune effi-
ciency and plasticity, which are in turn indispensable to
achieve health longevity. In this context, an interesting
aspect of the immune system, i.e. the liver extrathymic T-
cell pathway deputed to compensate the thymic failure in
ageing [8], shows variations during the circadian cycle in
young and very old mice, but not in old ones [20]. The
liver NKT cells bearing TCR αβ or γδ play an intriguing
role. These cells are the first sentinels for the host defence
against viruses and bacteria because secreting IL-2 and
IFN-γ, which in turn affect the activity of classic NK cells
[21]. These particular liver NKT cells display a circadian
rhythm in young and very old mice with significant mod-
ifications between the light and dark period. In particular,
the number of NKT γδ cells increases in young and very
old mice during the dark, whereas it remains unmodified
in old mice (Table 1). The number of NKT αβ cells dis-
plays an opposite trend with a decrement in young, old
and very old mice during the dark as compared to the light
period [15]. These findings suggest that NKT γδ cells may
be more involved in the maintenance of liver extrathymic
immune plasticity during ageing leading to a possible suc-
cessful ageing. This maintenance may be due to a better
preservation by cell death of NKT γδ cells than αβ because
of low Fas expression (CD95) in NKT γδ cells in oldest
individuals [22]. On the other hand, a significant decre-
ment in liver NKT cells expressing Fas (CD95) occurs in
very old mice in the dark as compared to old mice during
the same period [20]. By contrast, old mice display lower
number of NKT γδ cells for the whole circadian cycle,
impaired NKT γδ cell cytotoxicity and decreased produc-
tion of IL-2 and IFN-γ in comparison with very old mice
[15] (Table 1). Thus, the functionality and the number of
these cells, in particular of liver origin, are pivotal to reach
successful ageing because some age-related diseases, such
as infections, might be avoided. Indeed, old infected
patients display a lower number of NKT γδ cells than eld-
erly [23], giving further support to the relevance of liver
Table 1: Some biological and immune parameters in young (A), old (B) and very old mice (C) during the circadian cycle and during 
partial hepatectomy/liver regeneration. A parallelism with old and centenarians is reported.
MICE HUMANS
Circadian Cycle Partial Hepatectomy Old Centenarians
LP DP 0 h 48 h 15 gg
Number of NKTγδ 
cells
A ++ + MT A - +++ - MT +-
B -- -- B ++ +
C ++ + C -+ -
NKT cell 
cytotoxicity
A ++ +++ NKT cell 
cytotoxicity
A ++ - ++ NKT cell 
cytotoxicity
-+
B -- -- B -- -
C ++ + C +- +
IFNγ A ++ + Thymic endocrine 
activity
A ++ - ++ IFNγ -+
B -- B -- -
C ++ + C +- +
IL-2 A ++ + IL-2 A ++ - ++ IL-6 ++ ++
B -- B -- - gp 130 ++ -
C ++ + C +- +
Plasma zinc A ++ + Plasma Zinc A ++ - ++ Plasma zinc -+
B -- B -- -
C ++ + C +- +
+ = satisfactory ++ = high +++ = very high - = low -- = very low
LP = Light Period DP = Dark PeriodImmunity & Ageing 2007, 4:7 http://www.immunityageing.com/content/4/1/7
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NKT γδ cells for the host defence against viruses and bac-
teria [21].
Immune plasticity: model of the partial 
hepatectomy/liver regeneration in mice
Partial hepatectomy/liver regeneration (pHx) is a good
model for the study, other than the liver regeneration, of
acute and chronic inflammation in ageing because of the
likeness with ageing in impaired thymic endocrine activ-
ity, low zinc ion bioavailability and peripheral immune
efficiency (NK cell activity and IL-2 production) in young
pHx mice at 48 hr after pHx [14,24] (see Table 1). A com-
plete remodelling of zinc ion bioavailability and immune
efficiency however, occurs in the late period of compensa-
tory liver growth (7th and 15th day) in young pHx mice. By
contrast, no remodelling occurs in old mice displaying the
same low zinc ion bioavailability and impaired immune
functions for the whole period of the compensatory liver
growth (time 0, 48 hr, 7th and 15th day) [14] (Table 1).
These findings are intriguing because they suggest that
pHx is also a good model in order to show the immune
plasticity and, at the same time, the relevance of this plas-
ticity in liver extrathymic T-cell pathway during ageing.
This assumption is supported by the fact that very old pHx
mice show the same pattern in zinc ion bioavailability, in
liver NKT cell activity as well as in IL-2 production
observed in young pHx mice [20] (Table 1). In other
words, zinc ion bioavailability, liver NKT cell activity and
IL-2 production are not lost during the compensatory liver
growth in very old mice, but a remodelling occurs in the
late period of the liver regeneration (15th day), as occur-
ring in young pHx mice [20]. These findings in very old
mice, while on one hand demonstrate the presence of the
immune plasticity in very old age, on the other hand they
pinpoint that very old mice are still capable in responding
to a great inflammation, like partial hepatectomy, with a
remodelling of the liver immune efficiency.
This fact is very important in the oldest individuals
because it means that many age-related diseases may be
avoided in centenarians. As a consequence, very old indi-
viduals become "high responders" to oxidative stress and
inflammation, as occurring in the young [1,25]. Indeed,
the lack in responding to a great inflammation (like par-
tial hepatectomy) in old age provokes a shorter survival in
old pHx mice in comparison with old sham controls,
because old pHx mice display a greater incidence of cancer
and infections [24]. Thus, a good functioning of liver
extrathymic immune plasticity is pivotal to reach success-
ful ageing taking into account that liver extrathymic T-cell
pathway is prominent in ageing [8].
Immune plasticity: Lesson from Centenarian 
subjects
The study of human longevity and in particular the possi-
bility to remodel many body homeostatic mechanisms,
especially in remodelling some relevant immune func-
tions, such NK cell cytotoxicity, in very old age may pro-
vide intriguing insights in the understanding why some
organisms have the capacity to reach healthy ageing with
respect to normal elderly. Centenarians represent the lon-
gevity phenotype naturally occurring and they are the best
model because for the entire life a centenarian has taken
place in an environment that continuously pushed the
organism to cope with intrinsic and extrinsic antigenic
loads. On the other hand, no other organism has experi-
enced the rapid changes in hygiene, disease prevention,
technology, and other areas as those that occurred to
human populations in the last century, chiefly in devel-
oped countries. Therefore, the model of centenarians is
not simply a good model to study the human longevity,
with respect to well-studied animal models (see above),
but also provides unique insights into the complex net-
work of biological and non biological factors that guide
individual survival at old age. In this contest, the capacity
in remodelling the immune function (i.e. immune plas-
ticity) is fundamental to reach centenarian age. Such an
assumption is supported by some data on NKT γδ cells
obtained in human centenarians during the light period.
In these exceptional individuals, the major preservation of
NKT γδ cells [22] is coupled with satisfactory NKT cell
cytotoxicity and enhanced IFN-γ and IL-2 production
[23,26] (Table 1). Such a preservation and capacity to
maintain a satisfactory innate immune response is strictly
related to the inflammatory status and genes related to
inflammation. Among these genes, the MT homeostasis
and the intracellular zinc ion bioavailability, as reported
above, is fundamental in reducing inflammation with
subsequent achievement of successful of ageing. Indeed,
the analysis of some polymorphisms for the various iso-
forms of MT, mainly isoform I and II, confirms this
assumption. Recent findings show a novel polymorphism
of MT1A (in position +647 and with an aminoacid transi-
tion Asp/Asp in MT gene, called A/A genotype) involved
in successful of ageing and coupled with lower levels of IL-
6 and major intracellular free zinc ion availability [27]. In
contrast, old subjects carrying an aminoacid transition
Asp/Thr and Thr/Thr (called A/C and C/C genotypes,
respectively) display higher levels of IL-6 and low zinc ion
availability [27]. The same phenomenon also occurs for
another polymorphism for MT1A in position -197. A sig-
nificant increment of G+ genotype (GC and GG allele)
occurs in nonagenarian-centenarian subjects as compared
to old subjects carrying G- genotype (CC allele) suggesting
a predisposition of G+ subjects to the longevity. Subjects
carrying G+ genotype also provides less inflammation due
to lower circulating levels of IL-6, low gene expression ofImmunity & Ageing 2007, 4:7 http://www.immunityageing.com/content/4/1/7
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MT and higher intracellular zinc ion bioavailability [E.
Muti, unpublished results]. Although these findings are
strongly of interest because these novel MT polymor-
phisms are involved in longevity, some other genes
related to the inflammation are also involved in longevity.
The most relevant is the polymorphism of IL-6. In this
context, the polymorphism for a C to G transition at
nucleotide -174 of the IL-6 gene promoter (-174 C/G
locus) shows increased IL-6 production in C-(GG geno-
type) but not in C+ (CC and CG genotypes) old subjects,
and this phenomenon was significant only in males
[28,29]. Subsequently, it has been found that C- subjects
show also high MT and low intracellular zinc ion bioavail-
ability and impaired innate immune response [29]. More-
over, IL-6 -174 C/G polymorphism is an independent
predictor of cardiovascular death after an acute coronary
syndrome (ACS) in male patients [30] as well as in athero-
sclerosis worsening in old people (29). ACS patients car-
rying the IL-6-174 C-(GG) genotypes underwent a marked
increase in 1-year follow-up mortality rate (HR = 3.89,
95% CI 1.71–8.86, P = 0.001), thus suggesting that the IL-
6 -174 C/G polymorphism can be added to other clinical
markers in order to identify a subgroup of elderly ACS
male patients at a higher risk of death [30]. On the other
hand, ACS as well as some other cardiovascular diseases
(stroke and CAD) display high MT and high inflamma-
tory status coupled to low intracellular zinc ion bioavaila-
bility and impaired innate immunity [31]. Another
intriguing finding is the association with longevity of alle-
les of IL-10 and TNF-alpha known to have opposite func-
tions in inflammatory reactions, IL-10 acting
predominantly as an anti-inflammatory and TNF-alpha as
a pro-inflammatory factor. The combination of IL-10 and
TNF-alpha genotypes shows that there is a significant
increase of the "anti-inflammatory" (IL-10 -1082GG/
TNF-alpha -308GG) genotype (named A- subjects) in cen-
tenarian men over controls [32]. This finding is in agree-
ment with the recent discovery showing instead old
individuals carrying TNF-alpha -308 AA genotype (named
A+ subjects) more involved in infection relapses coupled
with low zinc intracellular zinc ion bioavailability,
increased MT, diminished IL-10 and impaired innate
immunity [33]. All these data suggest on one hand that
some polymorphisms of MT may be involved in longev-
ity, on the other hand that some other polymorphisms
related to inflammation (IL-6 and TNF-alpha) are
involved in the appearance of some age-related diseases
but, at the same time, these genes are strictly related to MT
homeostasis, zinc ion availability and immune plasticity.
Therefore, the MT gene may be the core of the complex
genetic network that regulates the inflammatory status
and, consequently, the longevity or the appearance of age-
related diseases. Indeed, some other MT polymorphisms
in position -209 (A/G genotype) is mainly involved in
atherosclerosis worsening and diabetes type II [34].
Mechanisms of action in maintaining the 
immune plasticity
It has been demonstrated that the zinc ion bioavailability
is fundamental for the efficiency of the immune system
[6,7]. The loss of zinc ions by intestinal malabsorption or
by reduced food intake provokes a zinc deficiency with
damage in cell-mediated immunity, including thymic effi-
ciency, NK cell activity, and cytokine production [35]. In
particular, during zinc deficiency some cytokines, such as
IL-2, IL-12, IFN-α, IFN-γ, decrease other cytokines, such as
TNF-α, IL-1, IL-6, increase [36]. In this context, zinc more
affects the cytokine production by Thl than Th2 cells [37].
That zinc has a beneficial effect on IFN-α production by
Th1 cells is supported by the discovery in virus transfected
cells showing a protein Staf-50 involved in a new family
of IFN-α production that contains two zinc finger motifs
[38]. More recently, zinc potentiates the antiviral action of
IFN-α tenfold [39]. These findings suggest an unbalance
of Thl/Th2 paradigm during zinc deficiency towards Th2
cytokine production [6,37], which leads to the induction
of some proteins deputed in fighting the oxidative stress.
In this context, metallothionein (MT) plays a pivotal role
because it sequesters and dispenses zinc [40]. MT acts as
antioxidant against wide spectrum of stressor agents,
because zinc-sulfur cluster is sensitive to changes of cellu-
lar redox state and oxidizing sites in MT (reduced number
of thiol groups) induce the transfer of zinc from its bind-
ing sites in MT to those of lower affinity in other proteins
[9,41]. This transfer occurs in conferring biological activ-
ity to antioxidant metalloenzymes, such as superoxide
dismutase, in the base excision DNA-repair by PARP-1, in
the genomic stability by telomerases, and, finally, in con-
ferring directly or indirectly, via zinc finger motifs, the
immune efficiency [10] (Fig. 1). Therefore, the redox
properties of MT and their effect on zinc in the clusters are
crucial for the biological functions of MT. Indeed, MT is
peculiar in cellular proliferation and in protecting cells
against cytotoxic effects of reactive oxygen species, ioniz-
ing radiations, electrophilic anti cancer drugs, mutagens
and heavy metals [9]. A peculiar role of MT is played dur-
ing partial hepatectomy/liver regeneration, with a strong
MT induction that is useful, other than in facilitating the
liver regeneration by various hepatocyte growth factors, in
protecting the cells by the inflammation after partial
hepatectomy. High MT, either as gene expression or pro-
tein, is present in young pHx mice at 48 h from pHx cou-
pled with low zinc ion bioavailability, high IL-6 and
impaired thymic and extrathymic T-cell pathways [14,24].
A complete down-regulation of MT and IL-6 followed by
a restoration of the immune efficiency occurs in the late
period of the compensatory liver growth (7th and 15th day
from pHx) [24]. By contrast, the high MT and IL-6 gene
expressions as well as the low zinc ion bioavailability and
the impaired immune functions, already present in old
mice, are not modified during the liver regeneration in oldImmunity & Ageing 2007, 4:7 http://www.immunityageing.com/content/4/1/7
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pHx mice. An intriguing aspect is the complete remode-
ling of MT, zinc ion bioavailability and immune function
in very old pHx mice at 7th and 15th day from partial hepa-
tectomy [24]. These findings further demonstrate that MT
is not protective against chronic inflammation, like in
ageing, because it is unable in release zinc, whereas its
protective role occurs in young-adult age [1]. Therefore,
MT turns from role of protection in young age to harmful
one in ageing due to its inability in zinc release [1]. This
phenomenon in ageing provokes low zinc ion bioavaila-
bility for zinc-dependent enzyme antioxidant activity, for
base excision DNA-repair by PARP-1, and for thymic and
extrathymic T-cell pathways. Therefore, MT follows the
"Antagonistic Pleiotropy Theory of Ageing" and plays a
pivotal role in zinc turnover in ageing and consequently
in conferring the immune plasticity. Such an assumption
is supported during the circadian cycle in which the high
nocturnal peaks of zinc and immune efficiency observed
in young and very old mice are related to low MT either as
gene expression or as protein [1]. No circadian variation
of MT occurs in old mice [1]. In addition, low MT gene
expression and good zinc ion bioavailability are also
observed in lymphocytes from centenarians [1]. This phe-
nomenon of MT in regulating zinc turnover is closely
dependent by the inflammatory status, in particular by the
gene expression and induction of pro-inflammatory
cytokines, such as IL-6, and of its sub-unit receptor gp130.
Although, IL-6 can elicit pro-inflammatory or anti-inflam-
matory effects depending on the in vivo environmental
circumstances [42], abnormal enhanced production of IL-
6 is an index of great inflammation and disability in age-
ing [43]. Also gp130 gene expression is constantly high in
ageing [44] leading to continuous increase of MT fol-
lowed by the stealing of intracellular zinc ions and no sub-
sequent zinc release by MT. As a consequence, low zinc
ion bioavailability appears in the maintenance of the
immune plasticity in ageing [1]. It is not a simple coinci-
dence that both very old mice and centenarians display
low gp130 despite IL-6 is high (44). This fact allows low
MT induction, good zinc ion bioavailability, satisfactory
immune efficiency and an increased capacity in base exci-
sion DNA repair by PARP-1 in very old age (mice and
humans). By contrast, high MT, IL-6 and gp130 coupled
with reduced capacity in base excision DNA repair are
present in elderly and in old infected patients [23]. In
these latter, alterations in DNA-repair and in MT are still
more severe. Indeed, abnormal high expression of MT is
an index of unfavourable prognosis in cancer and infec-
tions [45]. Therefore, zinc-bound MT homeostasis, via IL-
6 and gp130, is a fundamental mechanism in conferring
the immune plasticity in order to reach successful ageing.
MT can be thus considered a potential biological and
genetic marker of immunosenescence upstream affecting
functional biochemical cascade involved in the mainte-
nance of the immune plasticity, in particular liver NKT γδ
cells, with subsequent successful ageing.
Conclusion and future remarks
In conclusion, the zinc-bound MT homeostasis may be
considered a possible genetic marker of immunosenes-
cence affecting the immune plasticity and consequently
the achievement of successful ageing with a pleiotropic
role during the life: protective in young adult age and
harmful in elderly. This fact is evident in both experimen-
tal models herein described in order to show the relevance
of MT homeostasis in conferring the immune plasticity in
very old age. However, an intense debate has arisen during
the last decade around the possible dangerous or protec-
tive role of MT in old and very old age. In fact, in contrast
with their pleiotropic role, as suggest above, some authors
have found also evidence that MT over-expression may be
linked to enhanced survival and protection against oxida-
tive damage [46,47]. An intriguing hypothesis to resolve
this matter, is proposed for the first time in this manu-
script, regarding to the possible interplay between the
nutritional status and MT expression. The hypothesis is
that MT overexpression may be dangerous and thus linked
Schematic mechanism of the interplay between Metal- lothionein (MT), inflammation and stress Figure 1
Schematic mechanism of the interplay between Metal-
lothionein (MT), inflammation and stress. Infections and 
stress trigger an inflammatory response by increasing the 
production of pro-inflammatory cytokines which, in turn, 
stimulate the gene expression of Metallothioneins (which are 
produced as apo-MT). These proteins need zinc to properly 
absolve their function of zinc "releasers" during stressing 
condition. The zinc signal produced by release of zinc from 
Zn-MT is necessary to activate zinc dependent antioxidant 
and repairing enzymes, such as PARP-1, thus contributing to 
down-regulate stress and inflammation. The zinc pool which 
act as Zn++ reservoir for Zn-MT, is strictly dependent upon 
the dietary intake of this trace element, so that also dietary 
habits also contributes along with the genetic background to 
immune efficiency and plasticity.
Pro-inflammatory cytokines
Zn-MT
Zinc release by MT
Apo-MT
Zinc pool from extracellular
and intracellular stores
Dietary zinc
Base excision DNA-repair by PARP-1
Immune efficiency and plasticity
Stress
Infections
Dysfunctional Ox-MTImmunity & Ageing 2007, 4:7 http://www.immunityageing.com/content/4/1/7
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to shorter a dysregulated immune response and short sur-
vival when the nutritional status for zinc is impaired due
to low dietary intake of this trace element or to malab-
sorption, which in turn are common features in elderly
subjects [37]. The reasons to support this hypothesis arise
from the well known capability of intracellular free zinc
ion to suppress inflammation down-regulating the pro-
duction of TNF-alpha [48]. So that when the immune
inflammatory response has to be suppressed, free zinc
ions are released from MT to down-regulate the produc-
tion of TNF-alpha. However, in presence of an impaired
zinc status, during an inflammatory processes an high
expression of MT might be responsible of delaying the
anti-inflammatory pathway through sequestration of free
zinc ions. In addition, most of the MT might be oxidized
and their capability to produce an intracellular anti-
inflammatory zinc signal via NO-induced release might
be also impaired. Conversely, in presence of an adequate
zinc status, even if MT may be highly expressed, their
capability to release intracellular free zinc ions to activate
the anti-inflammatory pathway might be increased, with
a consequent rapid down-regulation of TNF-alpha. A
strong support to this hypothesis arise from experiments
on the influence of zinc deprivation or supplementation
on TNF-induced lethality in MT-null mice compared to
wild type [49]. In both mice strains, zinc deprivation
increased the susceptibility to TNF toxicity, but surpris-
ingly zinc deprived MT-null mice were more resistant than
zinc deprived wt mice. Conversely, zinc supplementation
displayed overall protective effects. A further support to
this hypothesis is that zinc supplementation in elderly
subjects can increase MT levels but decrease at the same
time inflammatory markers [E. Mocchegiani et al., prelim-
inary results from Zincage Project, unpublished], and that
optimal nutrition, including an adequate intake of zinc,
promotes functional health status, mental well associated
to reduced mortality [50,51]. In other words, MT homeos-
tasis might be the connecting link between environmen-
tal/genetic factor in determining the longevity. Therefore,
the capacity in remodelling immune functions (immune
plasticity), via MT homeostasis combined with an ade-
quate intake of zinc during the whole life, may represent
peculiar characteristics of those exceptional individuals
who reach the extreme limit of lifespan.
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